Glycoprotein Matrix-Bound Iron Improves Iron Absorption (NCT06738199) | Clinical Trial Compass
CompletedNot Applicable
Glycoprotein Matrix-Bound Iron Improves Iron Absorption
United States17 participantsStarted 2024-02-01
Plain-language summary
A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.
Who can participate
Age range18 Years – 45 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants had to have a normal body weight \[body mass index (BMI) of 19-24.99 kg/m2\] and engage in recreational physical activity, as defined by the American College of Sports Medicine guidelines.
* Participants must be healthy and have no diagnosed chronic disease conditions
Exclusion Criteria:
* Participants were not allowed to consume any nutritional supplements known to affect the measures of the current study for at least 6 weeks prior to participation, including pro-, post- and prebiotics, as well as digestive enzymes.
* Individuals who were currently being treated for or diagnosed with a gastrointestinal, cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, psychiatric, hematological, neurological, or endocrinological disorder.
* Participants whose body mass had deviated by more than 2% in the previous 30 days
* Participants who were unwilling to abstain from alcohol, nicotine, and caffeine for 12 hours prior to each visit.